0000899243-22-001199.txt : 20220106 0000899243-22-001199.hdr.sgml : 20220106 20220106163117 ACCESSION NUMBER: 0000899243-22-001199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220104 FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIEDEL NORBERT G CENTRAL INDEX KEY: 0001161662 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 22515167 MAIL ADDRESS: STREET 1: BAXTER INTERNATIONAL INC STREET 2: ONE BAXTER PKWY DF2-1W CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 JACOBS STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 222 JACOBS STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02141 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-04 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001161662 RIEDEL NORBERT G C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 1 0 0 0 Common Stock 2022-01-04 4 M 0 14270 A 42810 D Restricted Stock Units 2022-01-04 4 M 0 14270 0.00 D Common Stock 14270 0 D The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. 14,270 RSUs vested on January 4, 2022, the third anniversary of the vesting commencement date of January 4, 2019. /s/ Mark Bodenrader, as Attorney-in-Fact 2022-01-06